MS in the Media - 3 April 2020
28 March - 3 April 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Support for carers during the current situation
Informal and family carers need more support as they try to look after people while dealing with reduced help from health and care services warn the carer support charities. The story includes the experience of a couple affected by MS
Source: Daily Express
MS Trust link: A family talks about caring (written before the current situation)
Ozanimod approved for RRMS
Ozanimod (Zeposia), a drug for relapsing remitting MS that works in a similar way to Gilenya, has been approved for licensing by the European Medicines Agency (EMA).
Source: MS News Today
MS Trust link: Ozanimod (Zeposia)
My search for MS support while studying for a PhD
4 Mar 2021 - 00:00
Laura is studying a PhD in Cancer Genomics and was diagnosed with MS in September 2020 following multiple hospital admissions. Here, Laura talks about how this affected her mental health and what more could be done to support other students going through the same thing.
MS, my mental health and a university degree
4 Mar 2021 - 00:00
Scarlet talks about how she learnt to manage her MS and mental health alongside the stresses of completing a university degree.
Receiving an MS diagnosis during my gender transition
22 Feb 2021 - 00:00
Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
